The company has already begun interior construction and expects to have the facility ready for operations by 10 August 2016. This facility is expected to increase the company’s US production capacity by nearly twenty times.

This facility will be used to fulfil the company’s recently awarded contract from the US Government and to potentially supply additional collaborative textile developers.

Growth of production capacity

“This expanded domestic capacity should allow us to be more responsive to customers in both capacity and variety of spider silk materials,” said COO Jon Rice.

“This growth of our production capacity will allow us to expand our relationships with both industry and governmental collaborators. We are looking forward to the inauguration of this new production facility within the next two weeks.”

Kraig Biocraft Laboratories

Kraig Biocraft Laboratories, a fully reporting biotechnology company is a leading developer of genetically engineered spider silk based fibre technologies.

The company says its genetic engineering research has succeeded in developing a practical and cost-effective technology for producing recombinant spider silk based fibres on an industrial scale. Kraig Biocraft Laboratories is moving rapidly to commercialize its spider silk technology, which it believes will have a significant impact on the global textiles industry.

At the same time, the company are continuing to work in cooperation with leading laboratories to create new stronger and more flexible spider silk based fibres with potentially broad applications for consumers and industry in the multi-billion dollar marketplace for textiles and performance polymers.

Kraig Biocraft Laboratories receives contract from US Army to deliver Dragon Silk

www.kraiglabs.com